From: Prevalence and genetic diversity analysis of human coronaviruses among cross-border children
Parameter | No. (%) of non-HCoVs | No. (%) of HCoVs | |||||
---|---|---|---|---|---|---|---|
OC43 (n = 36) | HKU1 (n = 34) | NL63 (n = 6) | 229E (n = 2) | Total (n = 78) | |||
Gender | Male | 2184(97.6) | 22(1.0) | 25(1.1) | 5(0.2) | 1(0.0) | 53(2.4) |
Female | 1036(97.6) | 14(1.4) | 9(0.9) | 1(0.1) | 1(0.1) | 25(2.4) | |
Symptom | Hypothermia | 70(2.2) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
Fever | 3060(95.0) | 36(100.0) | 34(100.0) | 6(100.0) | 2(100.0) | 78(100.0) | |
Ardent fever | 305(9.5) | 2(5.6) | 2(5.9) | 0(0.0) | 0(0.0) | 4(5.1) | |
Running nose | 412(12.8) | 5(13.9) | 5(14.7) | 1(16.7) | 0(0.0) | 11(14.1) | |
Cough | 883(27.4) | 9(25.0) | 4(11.8) | 0(0.0) | 1(50.0) | 14(17.9) | |
Throat congestion | 1466(45.5) | 15(41.7) | 18(52.9) | 3(50.0) | 2(100.0) | 38(48.7) | |
Nasal obstruction | 36(1.1) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
Antiadoncus | 671(20.8) | 7(19.4) | 12(35.3) | 2(33.3) | 0(0.0) | 21(26.9) | |
Diarrhea | 16(0.5) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
Flush | 28(0.9) | 1(2.8) | 0(0.0) | 0(0.0) | 0(0.0) | 1(1.3) | |
Vomiting | 34(1.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
Hemoptysis | 1(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
Rash | 7(0.2) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
None | 38(1.2) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
Region | Mainland China | 2741(97.5) | 31(1.1) | 32(1.1) | 4(0.1) | 2(0.1) | 69(2.5) |
Hong Kong | 438(98.9) | 2(0.5) | 2(0.5) | 1(0.2) | 0(0.2) | 5(1.1) | |
Others | 41(91.1) | 3(6.7) | 0(0.0) | 1(2.2) | 0(0.0) | 4(8.9) |